Aioptics
14 employees on LinkedIn · 1 known investors
AI Optics develops AI software and portable imaging hardware for eye disease screening, designed to move diagnosis out of specialist offices and into point-of-care settings such as primary care and retail health clinics. It targets healthcare professionals seeking earlier, faster eye disease diagnosis.
Also known as AI Optics · AI Optics, Inc.
Founders & leadership
Investors · 1
Company profile
researched Aug 2026AI Optics, Inc. is a New York-based medical device and software company developing point-of-care retinal screening technology. It combines a handheld, rechargeable fundus camera with AI-based disease screening software modules, with the aim of allowing retinal images to be captured and assessed outside of specialist ophthalmology offices — for example during a routine primary care visit, where a medical assistant can screen a patient and deliver in-person results in under two minutes.
The company's shipping product is the Sentinel Camera, a handheld retinal imaging system built on proprietary optical technology and cleared through the FDA 510(k) pathway for capturing digital images of the human eye. A second product, Sentinel Pro, adds on-device screening software intended to identify retinal diseases including diabetic retinopathy, age-related macular degeneration and glaucoma; Sentinel Pro is not FDA-cleared and is described as being for investigational use only. Alongside the devices, the company offers EHR/DICOM integration, centralized deployment and training, and workflow consulting for integrating non-dilated retinal screening into routine visits, walk-ins and home visits.
Founding story
Co-founder and CEO Luke Moretti studied neuroscience at Vanderbilt University and attended New York University Grossman School of Medicine. He created AI Optics, founded in 2020, to widen access to retinal screening for patients who do not reach an eye specialist because of geography, cost or inconvenience.
Business model
AI Optics develops and sells its own imaging hardware and screening software, supported by services including EHR/DICOM integration, centralized training and deployment, and clinical workflow consulting for point-of-care screening programs.
Traction
The Sentinel Camera received FDA 510(k) clearance. The company was one of ten companies selected for cohort seven of the Luminate NY accelerator in Rochester, New York, and is a member organization of MTEC.
Latest developments
AI Optics announced FDA 510(k) clearance for the Sentinel Camera, a handheld retinal imaging system. Its Sentinel Pro on-device screening software remains a future, investigational-use product that is not FDA-cleared.
▸Full profile — market position, technology, go-to-market, geography
Market position
AI Optics positions its handheld device and screening software as a way to address gaps in retinal screening access, targeting an estimated 1.5 billion people the company says need screening, in a context where the American Academy of Ophthalmology recommends eye screening from age 40 and earlier for people with diabetes, high blood pressure or a family history of eye disease.
The company emphasizes purpose-built, in-house optical hardware paired with on-device AI screening, designed for simple use, low cost and easy implementation into existing clinical workflows, including non-dilated imaging and offline edge inference.
Technology
The company built its handheld imaging hardware and AI screening software modules in-house, using proprietary optical technology. Stated capabilities include color and infrared fundus imaging, non-mydriatic (non-dilated) retinal imaging, onboard/embedded image processing, on-device (edge) AI inference with offline operation and later synchronization to clinical systems, DICOM data management and EMR/EHR integration, in battery-powered portable form factors. AI Optics is listed as the assignee context for patents covering a portable medical diagnostics device with integrated artificial intelligence capabilities (US-11950847-B1), interchangeable imaging modules for such a device (US-12178392-B2), and identification of diseases with portable AI-enabled diagnostics instruments (US-12193746-B1).
Go-to-market
The company plans to introduce its device first to primary care clinics and then expand into the wider point-of-care market, including home health, retail health and eyeglass providers. It offers demos and direct inquiry through its website and has used the Rochester, New York optics, photonics and imaging community for manufacturing support.
Healthcare professionals and care settings outside specialist ophthalmology, beginning with primary care clinics and extending to a broader point-of-care market including home health providers, retail health clinics and eyeglass providers.
Geography
Headquartered at 145 Lexington Ave, New York, NY 10016, with manufacturing support drawn from the optics, photonics and imaging community in Rochester, New York.
Compiled by commissioned research from 7 cited public sources — announcements, filings, and press listed under research sources below.
Key figures
latest reportedCompany-reported or press-reported figures, each dated to when it was claimed — not independently audited.
Timeline · 2
launches, deals, and filingsAI Optics announced FDA 510(k) clearance for its Sentinel Camera, a handheld retinal imaging system intended to capture digital images of the human eye.
AI Optics was one of ten companies participating in cohort seven of the Luminate NY accelerator in Rochester, New York, an early-stage program for optics, photonics and imaging-enabled technologies.
Dated company events from announcements, filings, and press; legal rows summarize public dockets and regulator releases.
▸Research sources · 7
primary sources listed
- Aiopticsaioptics.ai · web
7 public sources were cited for this profile; the first-party ones are listed here.
Frequently asked questions
- What does Aioptics do?
- AI Optics builds handheld retinal imaging hardware and AI screening software for point-of-care eye disease detection.
- Who founded Aioptics?
- Aioptics was founded by Andrew DiGiore, Luke Moretti.
- Who are Aioptics's investors?
- Aioptics's investors include Mantis Capital.